Drug Database
SU

sumatriptan succinate (Zelrix / NP101 / Zecuity)

✓ Approved

Nupathe Inc. · HTR1D · 小分子

什么是 sumatriptan succinate?

sumatriptan succinate 是一种小分子,由Nupathe Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Topical、Transdermal。

药物档案

商品名Zelrix, NP101, Zecuity
公司Nupathe Inc.
药物类别小分子
分子靶点HTR1D
给药途径Topical, Transdermal
状态Approved

作用机制

分子靶点

sumatriptan succinate 作用于 1 个分子靶点:

HTR1D5-hydroxytryptamine receptor 1D (HTR1DA, HT1DA)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

sumatriptan succinate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersMigraine✓ Approved

相关研究文献

PubMedArchives of pathology & laboratory medicine2026-11-17

Tumors of the Genitourinary System Associated With Mutations in the Tricarboxylic Acid Cycle.

Liu Xiaoyang X, Dahl Douglas M DM, Wu Chin-Lee CL

Genetic alterations in tricarboxylic acid cycle enzymes such as succinate dehydrogenase, fumarate hydratase, and isocitrate dehydrogenase promote tumorigenesis and are increasingly identified across genitourinary tumors. To review the clinical and pathologic features of genitourinary tumors associated with mutations in succinate dehydrogenase, fumarate hydratase, and isocitrate dehydrogenase. This study is based on published literature and personal experience of the authors. Genitourinary tumors associated with mutations in tricarboxylic acid cycle enzymes have distinctive morphologic and molecular features and may be part of hereditary tumor syndromes. A systematic approach to understanding these neoplasms can help recognize the underlying syndromic predisposition in clinical practice, which permits appropriate surveillance not only for the patients but also for their families. Additionally, shared pathogenic mechanisms among these tumors provide insights into potential targeted and systemic therapies.

PMID 43042962
阅读全文 →
PubMedFrontiers in plant science2026-11-17

Elucidating the role of glucose-mediated redox homeostasis, carbohydrate metabolism, and secondary metabolite production in enhancing photosynthetic activity, ionomics, and yield in two okra (Abelmoschus esculentus) varieties.

Arif Yamshi Y, Ahmad Saif S, Singh Priyanka P, Alatar Abdulrahman A AA et al.

The objective of the research was to evaluate the most effective Glucose (Glc) dose for improving growth, physiological traits, and biochemical responses of two okra varieties, Sakata-713 and Neelam. At 25 days after planting, foliar treatment of different doses of Glc (0, 15, 30, 45, and 60 mM) was applied. At 30 and 45 days after sowing (DAS), sampling was conducted to analyse several physio-biochemical parameters, and 60 DAS yield traits were recorded. The data show that exogenous Glc treatment improved cell division, photosynthetic performance, gas exchange parameters, and mineral nutrient status. Furthermore, Glc treatment also improved activities of enzyme involved in carboxylation-decarboxylation balance (carbonic anhydrase) (CA), nitrogen assimilation (nitrate reductase) (NR), the Calvin cycle (Rubisco), glycolytic metabolism (hexo-kinase) (HXK), and the tricarboxylic acid cycle (succinate dehydrogenase (SDH) and fumarase (FUM)). This increase led to increase in production of osmolyte (proline), secondary metabolites (total phenols, flavonoids, and anthocyanins), and improved carbohydrate metabolism. The exogenous application of Glc maintained redox balance by reducing content of reactive oxygen species and lipid peroxidation with the help of antioxidant enzymatic scavenging system. The promotion effect of Glc followed the order: 30 mM > 45 mM > 15 mM > 60 mM > 0 mM. Moreover, Sakata-713, displayed more promising outcome than Neelam.

PMID 43041336
阅读全文 →
PubMedLangmuir : the ACS journal of surfaces and colloids2026-11-17

Molecular Dynamics Insights into Gas Transport in Multilayer Polymer Films.

Melnikova Sofia D SD, Larin Sergey V SV

Coextruded multilayer polymer films represent promising materials for packaging applications because of their controlled architecture and continuous processing. In this work, molecular dynamics (MD) simulations were performed to obtain a better understanding of the factors that can potentially influence the transport and distribution of gas molecules in multilayer polymer films. Three types of multilayer systems were considered: polylactide/poly(butylene succinate) (PLA/PBS), polylactide/poly-3-hydroxybutyrate (PLA/PHB), and polylactide/polyethylene (PLA/PE). A comprehensive detailed analysis of O2, CO2, and H2O transport in the multilayer systems with varied composition and compatibility of the polymers in the layers, different layer thicknesses, and crystallinity was carried out. In the case of PLA/PE films, significant anisotropy of gas diffusion for O2 and CO2 molecules was observed: the diffusion coefficient in the normal direction to the plane of the layers was much lower than that in the in-plane direction. This effect suggests that, in some cases, transport of gas molecules through a multilayer film perpendicular to the plane of the layers can be limited. It was found that the observed anisotropy of gas diffusion is caused by a combined effect of both the difference in size of free volume elements and the mobility of polymers in neighboring layers. Particularly, the passage of gas molecules from the PE layer to the PLA layer was hindered due to the difference in the size and speed of rearrangement of free volume elements for these polymers. This effect is purely interfacial and connected to the amorphous dynamics at the interfaces in the multilayer films.

PMID 43043037
阅读全文 →
PubMedInternational journal of food microbiology2026-11-16

A UV mutant library reveals a link between mitochondrial genome loss and succinate production during wine yeast fermentation.

Monnin Ludovic L, Nasution Indradoli I, Devillers Hugo H, Camarasa Carole C et al.

The wine industry must adapt to new climatic and societal challenges. For this, selected yeast strains, mainly Saccharomyces cerevisiae, is a powerful lever, with ultra-violet (UV) mutagenesis used successfully to generate genetic diversity for strain improvement. From a library of 502 mutants, phenotyped in wine conditions, we identified a bimodal distribution of certain primary metabolites production. Using a multi-scale fermentation approach (15 mL screening, 250 mL validation and 1 L characterization), we compare 10 low and 10 high succinate producers, under wine-like conditions. Primary metabolite profiles differed markedly, particularly in the production patterns of tricarboxylic acid cycle intermediates, with a twofold and threefold differences in succinate and α-ketoglutarate production respectively. Pyruvate and α-ketoglutarate accumulated earlier in low-succinate-producing strains, whereas succinate production was delayed, occurring mainly after the stationary phase. These patterns suggest altered TCA activity and are consistent with a model in which early pyruvate and α-ketoglutarate accumulation precedes later succinate production, although this proposed pathway sequence was not directly measured. Genomic analysis of 5 high and 5 low succinate producers revealed complete absence of the mitochondrial genome, potentially resulting in the absence of the respiratory chain. However, mitochondrial genome loss cannot alone explain the phenotype, as UV mutagenesis may also have generated other genomic and genetic changes. Our results suggest an association between mitochondrial genome status and organic acid production. We hypothesize that changes in redox balance, potentially involving fumarase activity and cofactor reoxidation, could contribute to the observed profiles; these mechanisms were not directly measured.

PMID 43038837
阅读全文 →
PubMedInternational journal of pharmaceutics2026-11-16

Evaluation of enteric polymer-based amorphous solid dispersions performance during pH-shift dissolution: insights for weakly acidic drugs.

Giareni Iliana I, Kapourani Afroditi A, Pantazos Ioannis I, Patitsa Maria M et al.

Amorphous solid dispersions (ASDs) formulated with enteric polymers are increasingly employed to improve the oral delivery of poorly water-soluble drugs. However, mechanistic investigations of their performance during gastrointestinal pH transitions (two- or three- stage dissolution studies) have focused predominantly on weakly basic compounds, leaving the behavior of weakly acidic active pharmaceutical ingredients (APIs) insufficiently understood. This study therefore sought to investigate the pH-shift dissolution behavior of weakly acidic APIs, using indomethacin (IND) as a model drug, in ASDs prepared with hydroxypropyl methylcellulose acetate succinate (HPMCAS) and hydroxypropyl methylcellulose phthalate (HPMCP). Polyvinylpyrrolidone (PVP) was also included as a non-enteric reference polymer for comparison. ASDs containing 25% and 40% (w/w) IND were prepared by melt-quench cooling and evaluated under one-stage intestinal conditions (pH6.8) and two-stage pH-shift conditions (pH1.6 → 6.8 and pH5.0 → 6.8), representing fasted- and fed-state gastric environments, respectively, before transition to intestinal conditions. Under one-stage intestinal conditions, PVP-based ASDs exhibited the highest dissolution performance, whereas the enteric polymers HPMCAS and HPMCP provided greater resistance to hydration-induced crystallization. During pH-shift dissolution, HPMCAS uniquely preserved its dissolution performance following exposure to pH5.0 (AUC ratio 1.04-1.05), while all other formulations exhibited reduced performance (AUC ratios 0.84-0.93). This behavior was accompanied by comparatively stable colloidal populations in HPMCAS-based ASDs, whereas solution-state 1H NMR revealed polymer-dependent molecular organization that did not directly correlate with dissolution or crystallization behavior. In contrast to previous studies on weakly basic drugs, where hydration-induced surface crystallization was identified as the primary factor governing subsequent intestinal drug release, the present systems exhibited a different physicochemical behavior, characterized by polymer-dependent molecular organization and colloidal evolution in the absence of detectable hydration-induced crystallization.

PMID 43035171
阅读全文 →
PubMedOpen medicine (Warsaw, Poland)2026-11-15

Succinate metabolism-related gene signatures enable diagnosis and prognostic stratification in early-stage hepatocellular carcinoma.

Wang Xiaomei X, Lu Yi Y, Ye Xiaoying X, Lv Jiaojian J

Succinate metabolism influences tumorigenesis through energetics, epigenetics, and immunity, yet the clinical value of succinate metabolism-related genes (SMRGs) in early-stage hepatocellular carcinoma (HCC) remains unclear. Using transcriptomic and clinical data from TCGA and GEO cohorts, we identified differentially expressed SMRGs (DESMRGs). Machine learning (LASSO, Random Forest, XGBoost) selected diagnostic biomarkers. Immune infiltration, immunotherapy response, and drug sensitivity were assessed via ssGSEA, CIBERSORT, TIDE, and pharmacogenomic databases. Twenty-four DESMRGs were identified in early-stage HCC. CDKN2A, LIFR, NTF3, and PVALB showed strong diagnostic potential (each AUC >0.70). Consensus clustering based on SMRGs defined two subgroups with distinct survival and pathway activities. A six-gene risk score stratified patients into high- and low-risk groups, validated externally. High-risk patients exhibited an immunosuppressive microenvironment, potential differences in immunotherapy-related response, higher TIDE scores, and distinct mutation and drug sensitivity profiles. SMRGs may serve as potential diagnostic and prognostic biomarkers for early-stage HCC and are closely linked to immune phenotypes and treatment implications. These findings suggest a potential association between succinate metabolism-related patterns and tumor immunity, supporting SMRG-based models for clinical risk stratification and therapy decisions in HCC, pending further validation.

PMID 43032493
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多sumatriptan succinate